Tyrosine kinase inhibitors in hematological malignancies
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2011, Vol 65, Issue 0
Abstract
Recently novel treatment modalities has focused on targeted therapies. Tyrosine kinases represent a good target for cancer treatment since they are involved in transferring phosphate groups from ATP to tyrosine residues in specific substrate proteins transducing intracellular signals engaged in the many mechanisms, playing an important role in the modulation of growth factors signaling that are strongly related to carcinogenesis. Deregulation of tyrosine kinases activity was also found in hematological malignancies, particularly overexpression of tyrosine kinases was observed in chronic myeloid leukemia or acute lymphoblastic leukemia. Herein we show that tyrosine kinase inhibitors have revolutionized hematology malignancies therapy in a very short period of time and they still remain one of the most interesting anticancer compounds that could give a hope for cure and not only long-lasting complete remission. This manuscript summarizes current view on the first generation tyrosine kinase inhibititor – imatinib, second generation – dasatinib, nilotinib and bosutnib as well as new generation tyrosine kinase inhibititors – ponatinib and danusertib in hematooncology.
Authors and Affiliations
Kamila Kosior, Magdalena Lewandowska-Grygiel, Krzysztof Giannopoulos
Keywords
Related Articles
- EP ID EP66585
- DOI -
- Views 167
- Downloads 0
Rola mikrośrodowiska nowotworowego w powstaniu i progresji czerniaka skóry
Czerniak jest nowotworem rozwijającym się z komórek barwnikowych umiejscowionych w skórze, w rzadszych przypadkach w oku oraz błonach śluzowych. Należy do grupy najbardziej agresywnych nowotworów, opornych na standardowe...
Ocena cytotoksycznego potencjału uszczelniaczy kanałowych po stwardnieniu – badania ex vivo
MAVS protein and its interactions with hepatitis A, B and C viruses
Mitochondrial antiviral signaling protein (MAVS) transmits activation signal of type I interferon (IFN) gene transcription in the molecular intracellular pathway, which depends on the protein encoded by retinoic acid ind...
Właściwości i różnorodność funkcjonalna dehydrogenazy aldehydu 3-fosfoglicerynowego
Dehydrogenaza aldehydu 3-fosfoglicerynowego (GAPDH) przez wiele lat uważana była za małointeresujące, klasyczne białko szlaku glikolitycznego. Wykorzystywano ją głównie jako modelowebiałko do badania struktury oraz mecha...
Methylprednisolone– acute spinal cord injury, benefits or risks?
Methylprednisolone is a synthetic glucocorticoid with a potent and long-acting anti-inflammatory, antiallergic and immunosuppressant. Its mechanism of action of methylprednisolone is the result of many cellular changes....